Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Department of Ophthalmology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Neuroradiology. 2021 Mar;63(3):391-398. doi: 10.1007/s00234-020-02540-7. Epub 2020 Aug 29.
This study aims to determine local diagnostic reference levels (LDRLs) of intra-arterial chemotherapy (IAC) procedures of pediatric patients with retinoblastoma (RB) to provide data for establishing diagnostic reference levels (DRLs) in pediatric interventional radiology (IR).
In a retrospective study design, LDRLs and achievable dose (AD) were assessed for children undergoing superselective IAC for RB treatment. All procedures were performed at the flat-panel angiography systems (I) ArtisQ biplane (Siemens Healthineers) and (II) Allura Xper (Philips Healthcare). Patients were differentiated according to age (A1: 1-3 months; A2: 4-12 months; A3: 13-72 months; A4: 73 months-10 years; A5: > 10 years), sex, conducted or not-conducted chemotherapy.
248 neurointerventional procedures of 130 pediatric patients (median age 14.5 months, range 5-127 months) with RB (68 unilateral, 62 bilateral) could be included between January 2010 and March 2020. The following diagnostic reference values, AD, and mean values could be determined: (A2) DRL 3.9 Gy cm, AD 2.9 Gy cm, mean 3.5 Gy cm; (A3) DRL 7.0 Gy cm, AD 4.3 Gy cm, mean 6.0 Gy cm; (A4) DRL 14.5 Gy cm, AD 10.7 Gy cm, mean 10.8 Gy cm; (A5) AD 8.8 Gy cm, mean 8.8 Gy cm. Kruskal-Wallis-test confirmed a significant dose difference between the examined age groups (A2-A5) (p < 0.001). There was no statistical difference considering sex (p = 0.076) and conducted or not-conducted chemotherapy (p = 0.627). A successful procedure was achieved in 207/248 cases.
We report on radiation exposure during superselective IAC of a pediatric cohort at the German Retinoblastoma Referral Centre. Although an IAC formally represents a therapeutic procedure, our results confirm that radiation exposure lies within the exposure of a diagnostic interventional procedure. DRLs for superselective IAC are substantially lower compared with DRLs of more complex endovascular interventions.
本研究旨在确定接受儿童视网膜母细胞瘤(RB)经动脉内化疗(IAC)的儿科患者的局部诊断参考水平(LDRL),为儿科介入放射学(IR)建立诊断参考水平(DRL)提供数据。
采用回顾性研究设计,评估在平板血管造影系统(I)ArtisQ 双平板(西门子医疗)和(II)Allura Xper(飞利浦医疗)上进行的用于治疗 RB 的超选择性 IAC 的儿童患者的 LDRL 和可实现剂量(AD)。根据年龄(A1:1-3 个月;A2:4-12 个月;A3:13-72 个月;A4:73 个月-10 岁;A5:>10 岁)、性别、是否进行化疗将患者进行区分。
2010 年 1 月至 2020 年 3 月期间,对 130 名患有 RB(68 例单侧,62 例双侧)的儿科患者的 248 次神经介入治疗过程进行了回顾性分析,中位年龄为 14.5 个月(5-127 个月)。以下诊断参考值、AD 和平均值可以确定:(A2)DRL 3.9 Gy·cm,AD 2.9 Gy·cm,平均值 3.5 Gy·cm;(A3)DRL 7.0 Gy·cm,AD 4.3 Gy·cm,平均值 6.0 Gy·cm;(A4)DRL 14.5 Gy·cm,AD 10.7 Gy·cm,平均值 10.8 Gy·cm;(A5)AD 8.8 Gy·cm,平均值 8.8 Gy·cm。Kruskal-Wallis 检验证实了所检查年龄组(A2-A5)之间的剂量差异有统计学意义(p<0.001)。考虑到性别(p=0.076)和是否进行化疗(p=0.627),差异无统计学意义。248 例中有 207 例手术成功。
本研究报告了德国视网膜母细胞瘤转诊中心儿科患者在超选择性 IAC 中的辐射暴露情况。虽然 IAC 从形式上看是一种治疗性手术,但我们的结果证实,辐射暴露与诊断性介入手术的辐射暴露处于同一水平。与更复杂的血管内介入干预相比,超选择性 IAC 的 DRL 要低得多。